Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients
Phase 4
- Conditions
- Renal Insufficiency, ChronicCardiac CatheterizationPercutaneous Coronary Intervention
- Interventions
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 600
- Registration Number
- NCT05225077
- Locations
- 🇰🇷
Dong A University Hospital, Busan, Korea, Republic of
Optimal Dosage of Ticagrelor in Korean Patients With AMI
Phase 4
- Conditions
- Acute Myocardial InfarctionTicagrelor
- Interventions
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2022-01-27
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 120
- Registration Number
- NCT05210595
- Locations
- 🇰🇷
DongA University Hospital, Busan, Korea, Republic of
Ticagrelor De-escalation Strategy in East Asian Patients With AMI
Phase 4
- Conditions
- Acute Myocardial Infarction
- Interventions
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2021-02-16
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 2000
- Registration Number
- NCT04755387
- Locations
- 🇰🇷
DongA University Hospital, Busan, Korea, Republic of
3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI
Phase 4
- Conditions
- ST Elevation Myocardial Infarction
- Interventions
- First Posted Date
- 2020-09-30
- Last Posted Date
- 2020-12-22
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 1002
- Registration Number
- NCT04570345
- Locations
- 🇰🇷
Department of Internal Medicine,Dong-A University College of Medicine, Busan, Korea, Republic of
Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy
Not Applicable
- Conditions
- Dilated Cardiomyopathy
- Interventions
- Diagnostic Test: FDG PET
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2020-08-26
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 40
- Registration Number
- NCT04174456
- Locations
- 🇰🇷
Department of Internal Medicine,Dong-A University College of Medicine, Busan, Korea, Republic of
Localization of Microvascular Dysfunction
Completed
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2019-11-20
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 115
- Registration Number
- NCT04169516
Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis
Phase 4
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: lidocaine/prilocaine (5%) applicationDrug: MAL applicationOther: Measurements of the fluorescence intensityDevice: irradiation with red light-emitting diode lamp
- First Posted Date
- 2018-11-06
- Last Posted Date
- 2018-11-06
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 47
- Registration Number
- NCT03731988
- Locations
- 🇰🇷
Dong-A University, Busan, Seo-gu, Korea, Republic of
Noninvasive Cardiac Imaging in Vasospastic Angina Korean Registry (NAVIGATOR)
Not Applicable
- Conditions
- Spasm
- Interventions
- Diagnostic Test: Spasm negativeDiagnostic Test: Spasm positive
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 90
- Registration Number
- NCT03570671
- Locations
- 🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of
Efficacy in Ablative Fractional Laser Assisted Photodynamic Therapy According to Ablative Depth for Actinic Keratosis
Phase 1
Completed
- Conditions
- Actinic Dermatosis
- Interventions
- Drug: lidocaine/prilocaine (5%) applicationDrug: MAL applicationOther: Measurements of the fluorescence intensityDevice: irradiation with red light-emitting diode lamp
- First Posted Date
- 2017-10-30
- Last Posted Date
- 2017-10-31
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 45
- Registration Number
- NCT03325803
- Locations
- 🇰🇷
Dong-A University, Busan, Seo-gu, Korea, Republic of, 602-715, Korea, Republic of
Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease
Phase 1
Completed
- Conditions
- Bowen's Disease
- Interventions
- Drug: methyl-aminolevulinate applicationDrug: lidocaine-prilocaine 5% cream applicationDevice: Illuminating using red light-emitting diode lamps
- First Posted Date
- 2017-10-25
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 60
- Registration Number
- NCT03320447
© Copyright 2025. All Rights Reserved by MedPath